TAOK3 (TAO kinase 3) is a serine/threonine-protein kinase belonging to the serine/threonine kinase STE20 family. It consists of an N-terminal catalytic domain.
Synonyms: Anti-CTCL tumor; Anti-Cutaneous T-cell lymphoma tumor antigen HD-CL-09; Anti-Dendritic cell-derived protein kinase; Anti-JNK/SAPK- inhibitory kinase; Anti-Jun kinase-inhibitory kinase; Anti-Serine/threonine-protein kinase TAO3; Anti-Thousand and one amino acid protein 3
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: TAOK3 (TAO kinase 3) is involved in the regulation of p38 MAPK (mitogen-activated protein kinase). It negatively regulates basal activity of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) pathway and EGF (epidermal growth factor) receptor activation repress its kinase activity. It also helps to activate p38 by ataxia telangiectasia mutated (ATM).
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC